Videos de Experimentos Relacionados

La mamografía de detección reevaluada fue reevaluada.

S W Duffy, L Tabar

Lancet (London, England)

|March 7, 2000

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Reply to Explaining variations in survival in breast cancer in the Eastern Region of England.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer.

British journal of cancer·2020

Same author

Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening.

European journal of radiology·2019

Same author

Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.

Breast (Edinburgh, Scotland)·2019

Same author

Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands).

Journal of medical screening·2018

Same author

The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

BMC cancer·2018

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

La mamografía de detección reevaluada fue reevaluada.

Videos de Conceptos Relacionados

Artículos Relacionados

Reply to Explaining variations in survival in breast cancer in the Eastern Region of England.

First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer.

Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening.

Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.

Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands).

The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

La mamografía de detección reevaluada fue reevaluada.

Videos de Conceptos Relacionados

Artículos Relacionados

Reply to Explaining variations in survival in breast cancer in the Eastern Region of England.

First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer.

Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening.

Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.

Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands).

The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.